Company intelligence / Profile preview
MD Stem Cells
Florida, United Statesmdstemcells.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
MD Stem Cells provides stem cell treatments for ophthalmic and neurologic diseases using adult, bone marrow-derived stem cells. Their therapies are conducted exclusively in the United States under FDA-compliant protocols, with Institutional Review Board approval and NIH registration. The company reports statistically significant results in peer-reviewed publications, with hundreds of patients treated and many experiencing meaningful improvements.
- Therapeutic areas
- OphthalmologyNeurology
- Modalities
- Stem cell therapyCell therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
The Healing Institute of Florida
Beyond the preview
Go deeper on MD Stem Cells.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MD Stem Cells.